C2C Wealth Management’s Amgen AMGN Stock Holding History

C2C Wealth Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$483K	Sell	1,145 -100	-8%	-$39.9K	0.38%	50
2026 Q2	$451K	Hold	1,245	–	–	0.35%	53
2026 Q1	$438K	Hold	1,245	–	–	0.37%	51
2025 Q4	$408K	Hold	1,245	–	–	0.34%	53
2025 Q3	$351K	Hold	1,245	–	–	0.3%	59
2025 Q2	$348K	Hold	1,245	–	–	0.31%	59
2025 Q1	$388K	Hold	1,245	–	–	0.36%	55
2024 Q4	$324K	Hold	1,245	–	–	0.3%	64
2024 Q3	$399K	Hold	1,245	–	–	0.37%	50
2024 Q2	$389K	Hold	1,245	–	–	0.38%	50
2024 Q1	$354K	Sell	1,245 -2,000	-62%	-$585K	0.35%	56
2023 Q4	$936K	Buy	3,245 +45	+1%	+$12.3K	0.79%	33
2023 Q3	$850K	Hold	3,200	–	–	0.12%	91
2023 Q2	$730K	Hold	3,200	–	–	0.1%	115
2023 Q1	$798K	Buy	3,200 +2,000	+167%	+$491K	0.13%	100
2022 Q4	$316K	Hold	1,200	–	–	0.05%	135
2022 Q3	$280K	Sell	1,200 -300	-20%	-$72.7K	0.05%	143
2022 Q2	$371K	Hold	1,500	–	–	0.07%	128
2022 Q1	$382K	Hold	1,500	–	–	0.07%	138
2021 Q4	$337K	Buy	+1,500	New	+$317K	0.05%	162

Other funds holding AMGN

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $127B AUM 33.25% 1-Year Est. Return

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

C2C Wealth Management's AMGN Position: Q3 2026 in Review

C2C Wealth Management reduced its Amgen (AMGN) stake by 8% in Q3 2026, selling an estimated $39.9K and leaving 1,145 shares worth $483K. The position accounts for 0.38% of the portfolio, ranked #50.

C2C Wealth Management first reported a position in AMGN in Q4 2021 and has held it in 20 quarters since. The position peaked at $936K in Q4 2023. 2,162 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

C2C Wealth Management held 1,145 shares of Amgen worth $483K as of Q3 2026.
C2C Wealth Management sold 100 Amgen shares in Q3 2026, an estimated $39.9K.
Amgen made up 0.38% of C2C Wealth Management's portfolio in Q3 2026, its #50 holding.
C2C Wealth Management first reported a position in Amgen in Q4 2021 and has held it in 20 quarters since.
C2C Wealth Management's Amgen position peaked at $936K in Q4 2023.
2,162 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on C2C Wealth Management's 13F filing for Q3 2026, filed 20 Oct 2026.